Skip to main content
      RT @synovialjoints: Hamroun S et al for the GR2 Cohort showed that age HR 1.22 and use of NSAIDs HR 3.01 in the pre-conc

      Dr. Antoni Chan synovialjoints

      2 years 5 months ago
      Hamroun S et al for the GR2 Cohort showed that age HR 1.22 and use of NSAIDs HR 3.01 in the pre-conception period was associated with a longer time to conception in women with SpA. Research is needed on continuous NSAID use in the preconception period #EULAR2022 @RheumNow OP0153 https://t.co/hl6jUlK5PN
      RT @Janetbirdope: #SLE responses with #anifrolimumab separate vs standard of care+placebo& LLDAS at 12 weeks-predict

      Janet Pope Janetbirdope

      2 years 5 months ago
      #SLE responses with #anifrolimumab separate vs standard of care+placebo& LLDAS at 12 weeks-predictor was high Type I IFN (younger, ⬆️disease activity) but diff sig for response w #belimumab. At bedside diff to tell pts with various signatures apart. #EULAR2022 @RheumNow Dorner https://t.co/98Sb3MIEps
      RT @Yuz6Yusof: #OP0143 #EULAR2022 We need to screen/monitor our patients with #lupus for infection. Amsterdam cohort (&g

      Md Yuzaiful Md Yusof Yuz6Yusof

      2 years 5 months ago
      #OP0143 #EULAR2022 We need to screen/monitor our patients with #lupus for infection. Amsterdam cohort (>200 pts) reported association of infection and flare. 50% were on steroid. Infection type did not influence flare @RheumNow https://t.co/Pxpx5hXLv9
      RT @AurelieRheumo: Dementia in RA associated w/
      ⚡️Large joint swelling HR 2
      ⚡️Any CVD HR 2.25
      ⚡️Anxiety HR 1

      Aurelie Najm AurelieRheumo

      2 years 5 months ago
      Dementia in RA associated w/ ⚡️Large joint swelling HR 2 ⚡️Any CVD HR 2.25 ⚡️Anxiety HR 1.86 ⚡️Depression HR 2.63 at any time during disease course in retrospective cohort 800+ pts #EULAR2022 @RheumNow OP0134 @MyasoedovaElena https://t.co/MLweRMEZXE
      RT @ericdeinmd: #EULAR2022 OP0135:
      German RABBIT 🐇 Registry:
      ⭐️ Observational, 46% Tofa, 54% Bari
      No increased ra

      Eric Dein ericdeinmd

      2 years 5 months ago
      #EULAR2022 OP0135: German RABBIT 🐇 Registry: ⭐️ Observational, 46% Tofa, 54% Bari No increased rate of CVD in JAK vs TNF inhibitor 🚨Unlike the ORAL Surveillance @RheumNow https://t.co/O4IXg22Ybc
      RT @synovialjoints: How many and quickly does nr-AxSpA progress to r-AxSpA? Poddubnyy et al for the PROOF study showed t

      Dr. Antoni Chan synovialjoints

      2 years 5 months ago
      How many and quickly does nr-AxSpA progress to r-AxSpA? Poddubnyy et al for the PROOF study showed that 16% of nr-AxSpA pts progressed to r-AxSpA within 5 years, mean time to radiographic progression was 2.4 years #EULAR2022 @RheumNow OP0149 https://t.co/KTC8Xkt4ey
      RT @synovialjoints: Good morning from Copenhagen. Starting the day with looking at imaging in SpA, review of posters, va

      Dr. Antoni Chan synovialjoints

      2 years 5 months ago
      Good morning from Copenhagen. Starting the day with looking at imaging in SpA, review of posters, vaccination, lupus nephritis and auto inflammatory disease #EULAR2022 @RheumNow https://t.co/aPEkLjDaK7
      RT @KDAO2011: Another promising drug for #SLE! Monoclonal Ab to BDCA2 ; phase II study noted improvement in joint manife

      TheDaoIndex KDAO2011

      2 years 5 months ago
      Another promising drug for #SLE! Monoclonal Ab to BDCA2 ; phase II study noted improvement in joint manifestation but not impressive in cutaneous dz. - Prof T Dorner #EULAR2022 @rheumnow https://t.co/eKwQyomJUD
      RT @Janetbirdope: #ClinicalPearl 2/3 of pts with #SLE have Type 1 interferon signature. So, 1/3 of #lupus is NOT driven

      Janet Pope Janetbirdope

      2 years 5 months ago
      #ClinicalPearl 2/3 of pts with #SLE have Type 1 interferon signature. So, 1/3 of #lupus is NOT driven by this pathway. Importance may be what is targeted in each pt but doesn’t necessarily predict response to #anifrolimumab #EULAR2022 @eular_org @RheumNow T Dorner SLE session https://t.co/vMOC8yGJ2V
      RT @ericdeinmd: #EULAR2022 OP0136:
      PROTECT-RA Cohort - 150 pts established RA
      Cholesterol loading capacity (CLC) on macr

      Eric Dein ericdeinmd

      2 years 5 months ago
      #EULAR2022 OP0136: PROTECT-RA Cohort - 150 pts established RA Cholesterol loading capacity (CLC) on macrophages ⭐️High CLC correlates with CV events ⭐️bDMARD use affects CLC @RheumNow https://t.co/9ngaH9yUI7
      RT @drdavidliew: Mortality after PMR:
      looking at 35y follow-up of a cohort in Norway,
      apparent higher mortality for wome

      David Liew drdavidliew

      2 years 5 months ago
      Mortality after PMR: looking at 35y follow-up of a cohort in Norway, apparent higher mortality for women (vs men, general population) decades after. Is this real? Treatment related? My wild guess: sarcopenia kills. Thoughts @Sarah_L_Mackie & tagged? OP0181 #EULAR2022 @RheumNow https://t.co/k7p9jNfW5s
      RT @Yuz6Yusof: #OP0144 #EULAR2022 Promising Digital use in monitoring disease activity for clinicians. Researchers in Am

      Md Yuzaiful Md Yusof Yuz6Yusof

      2 years 5 months ago
      #OP0144 #EULAR2022 Promising Digital use in monitoring disease activity for clinicians. Researchers in Amsterdam developed the first e-health #SLE T2T. High acceptance rate re: usability. Need more validation and in different languages @RheumNow https://t.co/7LravXhoJ8
      RT @drdavidliew: Sometimes hear “GCA associated with PMR is extracranial”

      Interesting point:
      of the 20% of PMR pati

      David Liew drdavidliew

      2 years 5 months ago
      Sometimes hear “GCA associated with PMR is extracranial” Interesting point: of the 20% of PMR patients with USS-evident subclinical GCA - one-quarter had isolated cranial disease GCA phenotypes not so clear cut (Proviso: it’s subclinical disease) OP0184 #EULAR2022 @RheumNow https://t.co/storHFL8aW
      RT @RichardPAConway: Farshad et al. 17% of admissions on long-term allopurinol had it held. Reasons - acute gout flare,

      Richard Conway RichardPAConway

      2 years 5 months ago
      Farshad et al. 17% of admissions on long-term allopurinol had it held. Reasons - acute gout flare, renal impairment, gastrointestinal issues, cytopenia, drug interactions, NPO status, and always discontinued the medication. @RheumNow #EULAR2022 OP0169 https://t.co/ADOomiOrRi https://t.co/nxAAOMWsJB
      RT @AurelieRheumo: RABBIT registry and MACE in RA
      No difference between
      *JAKi (Tofa and Bari) and *TNFi in both unselect

      Aurelie Najm AurelieRheumo

      2 years 5 months ago
      RABBIT registry and MACE in RA No difference between *JAKi (Tofa and Bari) and *TNFi in both unselected and high CV risks patients. 🧨 different than ORAL surveillance but Observational and overall Low incidence (28 events). #EULAR2022 @RheumNow OP0135 https://t.co/o8rngHrwQF